2609:TWSEYang Ming Marine Transport Corp. Analysis

Bayzed Health Group Inc trades around HK$3.49, which is dramatically above its DCF‑derived fair value of roughly HK$0.80, indicating a sizable overvaluation. The stock is perched between its 20‑day SMA (3.26) and 50‑day SMA (3.58) while the 200‑day SMA sits far higher at 5.74, and the technical picture is mixed – a bullish MACD histogram but an overall bearish trend direction and a neutral RSI of 53.
Fundamentally, the company posts negligible revenue growth (0.7%), thin gross margins (≈18%), and negative operating and profit margins, coupled with a modest debt‑to‑equity ratio of 35% and a negative ROE. High 30‑day volatility (≈64%) and a near‑zero beta suggest the stock moves largely on idiosyncratic factors, while increasing volume points to heightened trading interest despite the weak financial backdrop.